A lot of volatility on the major stock indices
Despite the lack of significant macroeconomic data, we could observe increased volatility in the stock market today.
The IFO reading from Germany turned out to be worse than expected, which caused declines in the stock markets in Europe. Nevertheless, the headlines regarding the coronavirus should also be blamed for today's sell-off. Merck has announced that it has discontinued development of its own vaccine, and Moderna confirmed that its vaccine produces less immune response to the new COVID-19 strain.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appWhile in Europe for most of the day sellers had a clear advantage, in the US the session looks different. The day started here with strong gains and both Nasdaq and Russell 2000 reached new all-time highs. Later in the session one could witness a sudden twist and sharp decline. Nevertheless, in the evening hours the demand recovers again, which means that US indices have a chance to erase recent losses by the end of the day. The Nasdaq is already trading 0.4% higher. However, US indices show a certain nervousness which, if it persists, may lead to a deeper correction in the near future.
US100 - after reaching a new record index pulled back rapidly among profit taking. Nevertheless, the main trend remains bullish. As long as we observe a sequence of higher highs and lows, there is no sign of a downturn. The nearest support lies at 13,100 pts level. Source: xStation
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
